Shikiar Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Shikiar Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.03M	Buy	14,950 +10,950	+274%	+$5.61M	2.03%	12
2026 Q1	$2.09M	Hold	4,000	–	–	0.6%	40
2025 Q4	$2.33M	Hold	4,000	–	–	0.58%	38
2025 Q3	$1.83M	Sell	4,000 -1,000	-20%	-$373K	0.46%	45
2025 Q2	$1.51M	Hold	5,000	–	–	0.42%	45
2025 Q1	$1.66M	Hold	5,000	–	–	0.49%	38
2024 Q4	$1.54M	Sell	5,000 -400	-7%	-$113K	0.41%	43
2024 Q3	$1.15M	Hold	5,400	–	–	0.3%	47
2024 Q2	$1.51M	Hold	5,400	–	–	0.4%	41
2024 Q1	$1.44M	Buy	5,400 +400	+8%	+$94.2K	0.42%	39
2023 Q4	$1.16M	Hold	5,000	–	–	0.36%	40
2023 Q3	$730K	Sell	5,000 -1,500	-23%	-$282K	0.25%	47
2023 Q2	$1.5M	Hold	6,500	–	–	0.48%	37
2023 Q1	$1.57M	Buy	+6,500	New	+$1.77M	0.56%	33
2022 Q3	$422K	Hold	6,500	–	–	0.17%	58
2022 Q2	$465K	Sell	6,500 -3,500	-35%	-$257K	0.18%	59
2022 Q1	$981K	Sell	10,000 -1,000	-9%	-$84.3K	0.28%	53
2021 Q4	$932K	Sell	11,000 -1,500	-12%	-$123K	0.24%	57
2021 Q3	$997K	Sell	12,500 -1,500	-11%	-$130K	0.28%	55
2021 Q2	$1.36M	Buy	14,000 +3,000	+27%	+$355K	0.39%	53
2021 Q1	$1.29M	Sell	11,000 -1,000	-8%	-$117K	0.43%	47
2020 Q4	$1.33M	Hold	12,000	–	–	0.48%	45
2020 Q3	$1.43M	Hold	12,000	–	–	0.55%	38
2020 Q2	$1.36M	Hold	12,000	–	–	0.62%	33
2020 Q1	$801K	Sell	12,000 -5,400	-31%	-$450K	0.54%	36
2019 Q4	$1.58M	Buy	17,400 +1,059	+6%	+$103K	0.52%	38
2019 Q3	$1.41M	Buy	16,341 +1,000	+7%	+$93.8K	0.56%	36
2019 Q2	$1.61M	Hold	15,341	–	–	0.63%	35
2019 Q1	$1.92M	Buy	15,341 +1,000	+7%	+$124K	0.81%	33
2018 Q4	$1.62M	Sell	14,341 -1,000	-7%	-$155K	0.85%	32
2018 Q3	$3.29M	Sell	15,341 -2,200	-13%	-$552K	1.28%	27
2018 Q2	$4.91M	Sell	17,541 -4,500	-20%	-$790K	2.05%	18
2018 Q1	$2.57M	Sell	22,041 -1,100	-5%	-$136K	1.17%	28
2017 Q4	$2.12M	Hold	23,141	–	–	0.99%	27
2017 Q3	$1.04M	Buy	23,141 +8,000	+53%	+$150K	0.45%	45
2017 Q2	$246K	Buy	+15,141	New	+$237K	0.11%	92

Other funds holding MDGL

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Waterloo Capital Austin, Texas $1.78B AUM 27.25% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Shikiar Asset Management's MDGL Position: Q2 2026 in Review

Shikiar Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 274% in Q2 2026, buying an estimated $5.61M and bringing the position to 14,950 shares worth $8.03M. The position accounts for 2.03% of the portfolio, ranked #12.

Shikiar Asset Management first reported a position in MDGL in Q2 2017 and has held it in 36 quarters since. 95 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Shikiar Asset Management held 14,950 shares of Madrigal Pharmaceuticals worth $8.03M as of Q2 2026.
Shikiar Asset Management bought 10,950 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $5.61M.
Madrigal Pharmaceuticals made up 2.03% of Shikiar Asset Management's portfolio in Q2 2026, its #12 holding.
Shikiar Asset Management first reported a position in Madrigal Pharmaceuticals in Q2 2017 and has held it in 36 quarters since.
95 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Shikiar Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.